Rahul Khara's most recent trade in Disc Medicine Inc was a trade of 1,161 Common Stock done at an average price of $54.6 . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 54.58 per share. | 18 Feb 2025 | 1,161 | 37,583 | - | 54.6 | 63,367 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 24,000 | 38,035 | - | 0 | Common Stock | |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.69 per share. | 03 Feb 2025 | 7,500 | 21,535 | - | 14.7 | 110,175 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 7,500 | 64,804 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 55.39 per share. | 03 Feb 2025 | 5,687 | 15,848 | - | 55.4 | 315,031 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 56.01 per share. | 03 Feb 2025 | 1,813 | 14,035 | - | 56.0 | 101,542 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.69 per share. | 02 Jan 2025 | 7,500 | 21,535 | - | 14.7 | 110,175 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 7,500 | 72,304 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 61.96 per share. | 02 Jan 2025 | 4,000 | 17,535 | - | 62.0 | 247,840 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 64.13 per share. | 02 Jan 2025 | 2,100 | 14,035 | - | 64.1 | 134,683 | Common Stock |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 62.95 per share. | 02 Jan 2025 | 1,400 | 16,135 | - | 63.0 | 88,135 | Common Stock |
| Disc Medicine Inc | Rahul Khara | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 21,050 | 21,050 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Rahul Khara | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 14,035 | 14,035 | - | 0 | Common Stock | |
| Disc Medicine Inc | Rahul Khara | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 28,770 | 28,770 | - | - | Stock Option (Right to Buy) |